ConductScience.org, home

Comparison · NCT00650585-01ee93ef

Treatment Group vs Control Group: Self-reported Lifetime Inhalant Use

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. Treatment Group vs Control Group: Self-reported Lifetime Inhalant Use. Trial comparisons, record NCT00650585-01ee93ef. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00650585-01ee93ef

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.1630.1490.179wilson
Risk in group 20.1450.1310.16wilson
Risk difference, group 1 minus group 20.018-0.002640.0387newcombe hybrid score
Risk ratio, group 1 over group 21.120.9831.29log
Odds ratio, group 1 over group 21.150.981.35log
Number needed to treat, for one more participant with the outcome on Treatment Group than on Control Group55.4from the risk difference intervalthe interval includes no difference

Groups2

Group 2 names the comparator: control.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1Treatment GroupSchool received Project ALERT, a substance use prevention program with 11 lessons the first year and 3 booster lessons the second year3792,324OG001
Group 2Control GroupSchool did not receive Project ALERT, a substance use prevention program3422,358OG000

Outcome

Type
PRIMARY
Title
Self-reported Lifetime Inhalant Use
Description
Students completed an 81-item self-report questionnaire. To assess lifetime use, we asked if the respondent had ever used inhalants (yes or no).
Time frame
measured approximately 30 days after intervention completed
Population
Data were cleaned to remove cases with logical inconsistencies which decreased our sample by 3.6% of respondents at pretest and 7.5% at post-test. Missing covariate data were imputed using the Expectation Maximization (EM) algorithm. Missing data were imputed using the EM algorithms implemented in the Missing Value Analysis module in SPSS 13.0.

Source ClinicalTrials.gov

Trial

Title
An Effectiveness Trial of Project ALERT
NCT number
NCT00650585
Phases
NA
Conditions
Alcohol Drinking, Smoking, Marijuana Smoking
Interventions
Project ALERT
Lead sponsor
Pacific Institute for Research and Evaluation
Results first posted
2009-10-21

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT00650585-01ee93ef